FGFR4 suppresses antitumor immunity and cuproptosis by disrupting CYLD-mediated stabilization of STING and FDX1

Hongguang Zhong1, Ruixuan Huang1, Wenyuan Deng2

  • 1Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China.

Cancer Letters
|August 19, 2026
PubMed

Insights

Fibroblast growth factor receptor 4 (FGFR4) suppresses antitumor immunity by degrading STING and FDX1. Inhibiting FGFR4 restores immune responses and enhances cancer treatment efficacy, offering a new therapeutic strategy.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Fibroblast growth factor receptor (FGFR) pathway dysregulation is common in cancer, promoting tumor growth and immune evasion.
  • The specific mechanisms by which the FGFR pathway suppresses antitumor immunity are not fully understood.

Purpose of the Study:

  • To identify key FGFR family members involved in immune suppression.
  • To elucidate the molecular mechanisms by which FGFR4 suppresses antitumor immunity.
  • To evaluate FGFR4 inhibition and cuproptosis induction as a combined therapeutic strategy.

Main Methods:

  • Investigated FGFR4's role in regulating antitumor immunity using molecular assays.
  • Examined the impact of FGFR4 on STING and FDX1 stability via GRB2-dependent CYLD inactivation.
  • Assessed the efficacy of combined FGFR4 inhibition (lenvatinib) and cuproptosis induction (elesclomol) in preclinical cancer models.
  • Correlated FGFR4 and STING expression with patient responses to anti-PD-1 therapy.

Main Results:

  • FGFR4 was identified as a suppressor of antitumor immunity.
  • FGFR4 inactivation of CYLD leads to STING and FDX1 degradation, impairing interferon signaling and cuproptosis sensitivity.
  • FGFR4 inhibition restored CYLD activity, stabilized STING and FDX1, and improved responses to STING agonists.
  • Combined lenvatinib and elesclomol synergistically reduced tumor growth in vivo.
  • High FGFR4 and low STING expression correlated with poor responses to anti-PD-1 therapy.

Conclusions:

  • FGFR4 is a critical regulator of antitumor immunity and cuproptosis.
  • Targeting FGFR4 in combination with cuproptosis inducers represents a promising therapeutic approach for cancer.
  • FGFR4-mediated immunosuppression presents a potential mechanism for resistance to immunotherapy.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...